Browsing by Author Irwig, L

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 6 to 13 of 13< previous 
Issue DateTitleAuthor(s)
1-Jan-2014General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: An experimental studyJansen, J; Bonner, C; McKinn, S; Irwig, L; Glasziou, P; Doust, J; Teixeira-Pinto, A; Hayen, A; Turner, R; McCaffery, K
7-Oct-2013General practitioners' use of different cardiovascular risk assessment strategies: a qualitative studyBonner, C; Jansen, J; McKinn, S; Irwig, L; Doust, J; Glasziou, P; Hayen, A; McCaffery, K
1-Jan-2018Legacy effects of statins on cardiovascular and all-cause mortality: A meta-analysisNayak, A; Hayen, A; Zhu, L; McGeechan, K; Glasziou, P; Irwig, L; Doust, J; Gregory, G; Bell, K
29-Jan-2011Monitoring adherence to drug treatment by using change in cholesterol concentration: Secondary analysis of trial dataBell, KJL; Kirby, A; Hayen, A; Irwig, L; Glasziou, P
10-Dec-2011Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanomaTurner, RM; Bell, KJL; Morton, RL; Hayen, A; Francken, AB; Howard, K; Armstrong, B; Thompson, JF; Irwig, L
1-Jan-2012The potential value of monitoring bone turnover markers among women on alendronateBell, KJL; Hayen, A; Irwig, L; Hochberg, MC; Ensrud, KE; Cummings, SR; Bauer, DC
1-Apr-2018Prognostic impact of systolic blood pressure variability in people with diabetesBell, KJL; Azizi, L; Nilsson, PM; Hayen, A; Irwig, L; Östgren, CJ; Sundröm, J
4-May-2013When to remeasure cardiovascular risk in untreated people at low and intermediate risk: Observational studyBell, KJL; Hayen, A; Irwig, L; Takahashi, O; Ohde, S; Glasziou, P